R

Avidity Biosciences
D

RNA

43.240
USD
0.66
(1.55%)
مغلق
حجم التداول
26,569
الربح لكل سهم
-3
العائد الربحي
-
P/E
-15
حجم السوق
5,158,934,867
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.09500
    (-1.60%)
    5.85500 USD
    A
    ALLO
    -0.19000
    (-7.71%)
    2.27500 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    C
    CRIS
    -0.04000
    (-1.00%)
    3.96000 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    R
    RGNX
    -1.51500
    (-13.60%)
    9.62500 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    المزيد
الأخبار

العنوان: Avidity Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.